Experts question Amarin's early touting of Vascepa data ahead of detailed results
At the end of September, Amarin teased some early findings for Vascepa, its preventive medicine for people at risk of heart disease. The claim was …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
